Newmont Rallies 175.8% in Year; Options Strategy Could Yield 35%
Newmont shares have surged 175.8% over the past year on gold-price gains. Investors are exploring an options strategy for a potential 35% short-term return while the bioleaching market, forecast to reach $21.37B by 2033 at 8.9% CAGR, could lower Newmont’s extraction costs.
1. Share Performance
Newmont’s share price has climbed 175.8% over the last 12 months, mirroring a 77.5% rally in gold prices to above $5,160 per ounce. This performance far exceeds the Basic Materials sector’s 51.2% gain and the S&P 500’s 20.8% advance.
2. Options Strategy
A newly discussed options setup targets a 35% return within weeks by combining near-term call purchases with higher-strike call sales. Traders are weighing the risk-reward profile given Newmont’s recent volatility and strong bullish momentum.
3. Bioleaching Opportunity
The global bioleaching market is projected to expand from $10.14B in 2024 to $21.37B by 2033 at an 8.9% CAGR. Adopting bioleaching techniques could enable Newmont to cut cash costs per ounce and bolster its sustainability credentials.